WO2008105260A1 - 下肢切断手術の予後を改善する治療剤 - Google Patents

下肢切断手術の予後を改善する治療剤 Download PDF

Info

Publication number
WO2008105260A1
WO2008105260A1 PCT/JP2008/052694 JP2008052694W WO2008105260A1 WO 2008105260 A1 WO2008105260 A1 WO 2008105260A1 JP 2008052694 W JP2008052694 W JP 2008052694W WO 2008105260 A1 WO2008105260 A1 WO 2008105260A1
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic agent
ameliorating
prognosis
lower limb
limb amputation
Prior art date
Application number
PCT/JP2008/052694
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
Yutaka Mizushima
Masahiro Murakami
Original Assignee
Ltt Bio-Pharma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ltt Bio-Pharma Co., Ltd. filed Critical Ltt Bio-Pharma Co., Ltd.
Priority to CN2008800063978A priority Critical patent/CN101622003B/zh
Publication of WO2008105260A1 publication Critical patent/WO2008105260A1/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
PCT/JP2008/052694 2007-02-28 2008-02-19 下肢切断手術の予後を改善する治療剤 WO2008105260A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008800063978A CN101622003B (zh) 2007-02-28 2008-02-19 改善下肢截肢手术的预后的治疗剂

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-049363 2007-02-28
JP2007049363 2007-02-28

Publications (1)

Publication Number Publication Date
WO2008105260A1 true WO2008105260A1 (ja) 2008-09-04

Family

ID=39721096

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/052694 WO2008105260A1 (ja) 2007-02-28 2008-02-19 下肢切断手術の予後を改善する治療剤

Country Status (2)

Country Link
CN (1) CN101622003B (es)
WO (1) WO2008105260A1 (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0710833A (ja) * 1991-04-16 1995-01-13 Yutaka Mizushima プロスタグランジン類縁体、その脂肪乳剤およびその用途
WO1999009992A1 (fr) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
WO1999011268A1 (fr) * 1997-08-28 1999-03-11 Yoshitomi Pharmaceutical Industries, Ltd. Agents promoteurs et agents potentialisateurs de la neovascularisation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0710833A (ja) * 1991-04-16 1995-01-13 Yutaka Mizushima プロスタグランジン類縁体、その脂肪乳剤およびその用途
WO1999009992A1 (fr) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
WO1999011268A1 (fr) * 1997-08-28 1999-03-11 Yoshitomi Pharmaceutical Industries, Ltd. Agents promoteurs et agents potentialisateurs de la neovascularisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ITO M.: "Heisokusei Domyaku Kokasho -Gainen.Bunrui.Shindan.Chiryo-", SHINJIDAI NO TONYOBYOGAKU (4) - BYOIN.SHINDAN.CHIRYO KENKYU NO SHINPO-, KABUSHIKI KASIHA NIPPON RINSHOSHA, 28 October 2002 (2002-10-28), pages 334 *

Also Published As

Publication number Publication date
CN101622003B (zh) 2012-03-21
CN101622003A (zh) 2010-01-06

Similar Documents

Publication Publication Date Title
NZ586751A (en) Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function
NZ589445A (en) Rasagiline for parkinson's disease modification
BRPI0509863A (pt) liberação de fármaco para fundo de olho
WO2007017135A3 (en) Process for the preparation of olmesartan medoxomil
WO2010136474A3 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
EP1834637A4 (en) COMPOSITION FOR THE PREVENTION / TREATMENT OF DISEASES THROUGH FREE RADICALS
AR047993A1 (es) Composicion farmaceutica que comprende pimobendano
WO2008069941A3 (en) Modified release ibuprofen solid oral dosage form
WO2006037031A3 (en) Formulations and methods for treatment of inflammatory diseases
WO2007048801A3 (en) Sexual desire enhancing medicaments comprising benzimidazolone derivatives
WO2010088000A3 (en) Antifibrotic compounds and uses thereof
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
UA96575C2 (en) Process for the preparation of olmesartan medoxomil
WO2012021107A3 (en) A liposomal formulation for ocular drug delivery
BR112012016783A2 (pt) "usos do composto de naltrexona ou sal farmaceuticamente aceitável da mesma a bupropiona ou sal farmaceuticamente aceitável da mesma ou de composição dos mesmos e métodos para proporcionar terapia"
WO2009028605A1 (ja) 抗がん剤による末梢神経障害の予防又は軽減剤
WO2008008701A3 (en) Substituted cyclopentane derivatives as therapeutic agents
WO2010075315A3 (en) Topical formulations of flap inhibitors for administration to an eye
WO2012012305A3 (en) Combination therapy using a ruthenium complex
WO2007145863A3 (en) Sustained release formulation of naltrexone
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2008133297A1 (ja) ジスキネジアの治療または予防剤
EA201171087A1 (ru) СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
WO2011049979A3 (en) Injectable formulations for intra- articular or peri-articular administration

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880006397.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08711518

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08711518

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP